Social Anxiety Virtual Reality Study

NCT04288180 | Terminated

• 1 other identifier: IRB-48367
• Study Type: observational
• Target: 4
• Locations: 1 country
• Sites: 1

Brief Summary

This project aims to validate a virtual reality paradigm that assesses maladaptive avoidance behavior in social anxiety disorder. It also aims to generate a significant scientific advance by testing the hypothesis that maladaptive avoidance maintains anxiety through disruptions in safety learning.

Conditions

Social Anxiety Disorder

Outcome Measures

Primary Outcomes (1)

• Maladaptive Avoidance Behavior

  Latency (in milliseconds) to enter the quadrant of the avoidance task containing the image from the fear learning task

  Baseline

Secondary Outcomes (2)

• Maladaptive Avoidance Behavior (alternate measure)

  Baseline

• Maladaptive Avoidance Behavior (2nd alternate measure)

  Baseline

Study Arms (1)

Social Anxiety Disorder

A group of adults with social anxiety disorder will be recruited for a psychological/behavioral research study.

Other: No intervention

Interventions

No intervention OTHER

There will be no intervention in this study. Adults with social anxiety disorder will complete research assessments related to fear and safety learning.

Social Anxiety Disorder

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults with primary social anxiety disorder, community sample

You may qualify if:

• age 18+
• primary diagnosis of social anxiety disorder
• fluent spoken and written English
• able to provide informed consent

You may not qualify if:

• history of manic episode, hypomanic episode, or psychosis
• moderate or severe substance use disorder in the past 12 months
• current major depressive episode greater than moderate severity (PHQ-9 score \>14)
• high risk for suicide (\>8 on the MINI Suicidality section and/or clinician judgment that immediate medical attention is necessary)
• general medical condition or impediment to vision, hearing, or motor function likely to interfere with assessments
• benzodiazepine use in the past 2 weeks
• cannabis use for anxiety management in the past 2 weeks

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic Disorders; Anxiety Disorders; Mental Disorders

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Instructor

Study Record Dates

• First Submitted: February 25, 2020
• First Posted: February 28, 2020
• Study Start: January 15, 2020
• Primary Completion: February 28, 2020
• Study Completion: February 28, 2020
• Last Updated: October 8, 2021

Record last verified: 2021-09

Locations

US (1)